Latest News

You are here

28
Nov

ONDRI annual workshop outcomes

workshop 2016 group photos.JPG

Thank you to everyone who attended the ONDRI workshop in London in October. It was a wonderful opportunity to meet colleagues face-to-face and discuss achievements, preliminary data and plans for the next phase of ONDRI 2.0.

Special guests from the OBI Science Innovation Team, OBI Core Innovation Team and Patient Advisory Committee's provided helpful ideas for collaboration and direction and left feeling excited about ONDRI.

23
Nov

Meet: Dr. Sali Farhan, genomics

Sali Farhan.jpgIf money was no object, what would you do all day?

One of my major life goals is to start a scholarship program with a central focus on science, technology, engineering, and math (STEM) for young women from underdeveloped or developing nations.

Immigrating to Canada provided me with many opportunities that many young girls still do not have today. I would love to “pay it forward” and continue to work in research and possibly collaborate with many nations and maybe one day, Iraq. If I were ever successful in developing such a program, I would hope to spend my days teaching genetics and biochemistry to young students and help them grow into curious, passionate, and successful scientists.

9
Nov

OBI President's Update

Tom Mikkelsen - Copy.jpgRead Dr. Tom Mikkelsen's, President & Scientific Director at Ontario Brain Institute (OBI), latest update to learn about program renewal, Integrated Discovery Program (IDP) research updates, media coverage, and how OBI is making an impact on research, the economy, and health.

Read previous updates.

4
Nov

Media: Progress in ALS, which took life of Mauril Belanger, accelerating: researchers

Lorne Zinman.jpgRead as Dr. Lorne Zinman explains how the pace of ALS discovery has been accelerated. 

“All the muscles that you can control are the ones you lose,” explains Dr. Zinman. “You become paralyzed and basically locked in.”

"A number of genes that underlie inherited cases of the disease have been identified. We understand the pathology better, we understand how the disease progresses better, we’re understanding how interventions can help patients survive longer.”